SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-009596
Filing Date
2018-04-27
Accepted
2018-04-27 16:31:15
Documents
60
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20180331.htm 10-Q 1203928
2 EX-31.1 sbph-ex311_6.htm EX-31.1 18462
3 EX-31.2 sbph-ex312_8.htm EX-31.2 18175
4 EX-32.1 sbph-ex321_7.htm EX-32.1 16336
  Complete submission text file 0001564590-18-009596.txt   5790254

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20180331.xml EX-101.INS 1421627
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20180331.xsd EX-101.SCH 42806
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20180331_cal.xml EX-101.CAL 41322
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20180331_def.xml EX-101.DEF 142475
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20180331_lab.xml EX-101.LAB 343095
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20180331_pre.xml EX-101.PRE 263932
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 18784440
SIC: 2834 Pharmaceutical Preparations